Serumwerk Bernburg

Serumwerk Bernburg AG is a prominent German pharmaceutical company specializing in the development and production of human and veterinary medicines, as well as medical devices. Founded in 1954 and headquartered in Bernburg, the company is a global leader in the manufacture of iron-dextran complexes used to treat iron deficiency in both humans and livestock. Their extensive portfolio includes infusion solutions such as hydroxyethyl starch (HES) and dextran for volume replacement, alongside a variety of veterinary vaccines and anti-infectives. In addition to its proprietary products, Serumwerk Bernburg serves as a specialized CDMO, offering GMP-compliant manufacturing for large-volume parenterals and complex chemical syntheses. The company maintains a strong international footprint, exporting its high-quality medical products to more than 90 countries.